SARS-CoV-2-specific T cells in the changing landscape of the COVID-19 pandemic

A Bertoletti, N Le Bert, AT Tan - Immunity, 2022 - cell.com
Since the onset of the coronavirus disease 2019 (COVID-19) pandemic, multiple severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants with increasing ability to …

SARS-CoV-2 hybrid immunity: silver bullet or silver lining?

R Suryawanshi, M Ott - Nature Reviews Immunology, 2022 - nature.com
SARS-CoV-2 hybrid immunity: silver bullet or silver lining? | Nature Reviews Immunology Skip to
main content Thank you for visiting nature.com. You are using a browser version with limited …

Predicting the efficacy of variant-modified COVID-19 vaccine boosters

DS Khoury, SS Docken, K Subbarao, SJ Kent… - Nature Medicine, 2023 - nature.com
Booster vaccination for the prevention of Coronavirus Disease 2019 (COVID-19) is required
to overcome loss of protection due to waning immunity and the spread of novel severe acute …

Predicting vaccine effectiveness against severe COVID-19 over time and against variants: a meta-analysis

D Cromer, M Steain, A Reynaldi, TE Schlub… - Nature …, 2023 - nature.com
Vaccine protection from symptomatic SARS-CoV-2 infection has been shown to be strongly
correlated with neutralising antibody titres; however, this has not yet been demonstrated for …

The T-cell-directed vaccine BNT162b4 encoding conserved non-spike antigens protects animals from severe SARS-CoV-2 infection

CM Arieta, YJ Xie, DA Rothenberg, H Diao, D Harjanto… - Cell, 2023 - cell.com
T cell responses play an important role in protection against beta-coronavirus infections,
including SARS-CoV-2, where they associate with decreased COVID-19 disease severity …

Key lessons from the COVID-19 public health response in Australia

JM Basseal, CM Bennett, P Collignon… - The Lancet Regional …, 2023 - thelancet.com
Australia avoided the worst effects of the COVID-19 pandemic, but still experienced many
negative impacts. Reflecting on lessons from Australia's public health response, an …

Memory T cells effectively recognize the SARS-CoV-2 hypermutated BA. 2.86 variant

TR Müller, Y Gao, J Wu, O Ribeiro, P Chen… - Cell host & …, 2024 - cell.com
T cells are critical in mediating the early control of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) breakthrough infection. However, it remains unknown whether …

Correlates of protection against symptomatic SARS-CoV-2 in vaccinated children

Y Zhong, AYH Kang, CJX Tay, HE Li, N Elyana… - Nature medicine, 2024 - nature.com
The paucity of information on longevity of vaccine-induced immune responses and
uncertainty of the correlates of protection hinder the development of evidence-based COVID …

Toward a pan-SARS-CoV-2 vaccine targeting conserved epitopes on spike and non-spike proteins for potent, broad and durable immune responses

CY Wang, WJ Peng, BS Kuo, YH Ho, MS Wang… - PLoS …, 2023 - journals.plos.org
Background The SARS-CoV-2 non-Spike (S) structural protein targets on nucleocapsid (N),
membrane (M) and envelope (E), critical in the host cell interferon response and memory T …

[HTML][HTML] Impact of SARS-CoV-2 exposure history on the T cell and IgG response

R Keeton, MB Tincho, A Suzuki, N Benede… - Cell Reports …, 2023 - cell.com
Multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exposures, from
infection or vaccination, can potently boost spike antibody responses. Less is known about …